Health
Researchers identify biomarkers that predict patient’s response to metformin treatment – News-Medical.net
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
Reviewed by Emily Henderson, B.Sc.Sep 18 2020
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient will respond to metformin treatment via a simple blood test.
Our study constitutes…
-
General21 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News17 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News10 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General10 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final